IP Library Granted Patent US 11,118,143
Granted Patent B2
US 11,118,143 · App. 15/751,076 · Granted Sep 14, 2021

Antimicrobial composition having efficacy against endospores

Inventor: Matthew Franco Myntti (St. Augustine, FL)
Assignee: Next Science IP Holdings Pty Ltd
C11D3/38636A01N37/46A01N59/00C11D1/02C11D1/83C11D1/835C11D1/94C11D3/0047C11D3/046C11D3/2068C11D3/2075C11D3/38618C11D3/38645C11D3/43C11D3/48
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,118,143
App. No.
15/751,076
Granted
Sep 14, 2021
Kind
B2
Abstract

A sporicidal composition has a moderately low pH and includes a glycosidase and the dissocia-tion product of at least one inorganic oxidizing agent. High effective solute concentrations can enhance the efficacy of the composition. The composition can be applied to a surface and allowed to absorb into an endospore, ultimately killing at least some of those bacteria in mature endospore form. Surfaces to be treated include inanimate (hard) surfaces via cleaning and medical devices such as endoscopes, typically via immersion.

Claims (34)

1. A composition useful for treating surfaces susceptible to carry endospores, comprising:

a) a solvent component that comprises water and one or more organic liquids, said solvent component exhibiting a δ p value of from 13.1 to 15.7 MPa ½ , and

b) a solute component that comprises

(1) a buffer provided by combining at least one carboxylic acid and conjugate base of at least one carboxylic acid,

(2) dissociation product of from 4 to 18 g/L of one or more electrolyte oxidizing agents, each of said electrolyte oxidizing agents being a compound that comprises an anion selected from the group consisting of manganate, permanganate, peroxochromate, chromate, dichromate, and peroxymonosulfate,

(3) from 0.05 to 1 g/L of a lysozyme, and

(4) from 5 to 30 g/L of an ionic surfactant,

said composition having a pH of from about 4.75 to about 6.5 and an effective solute concentration of at least 0.5 Osm/L.

2. The composition of claim 1 wherein said ionic surfactant is an anionic surfactant.

3. The composition of claim 1 wherein said one or more organic liquids comprises at least one glycol ether.

4. The composition of claim 1 wherein said solute component further comprises nonionic surfactant.

5. The composition of claim 4 wherein said ionic surfactant is an anionic surfactant.

6. The composition of claim 4 wherein said solute component further comprises dissociation products of one or more non-oxidizing electrolytes.

7. The composition of claim 2 wherein said solute component further comprises dissociation products of one or more non-oxidizing electrolytes.

8. The composition of claim 1 wherein said solute component further comprises dissociation products of one or more non-oxidizing electrolytes.

9. The composition of claim 8 wherein said composition is free of oxidizing acids.

10. The composition of claim 1 wherein said composition is free of oxidizing acids.

11. The composition of claim 1 wherein at least one of said one or more electrolyte oxidizing agents has an E 0 red value of at least +1.5 V.

12. A composition useful for treating surfaces susceptible to carry endospores, said composition being free of oxidizing acids and consisting of:

a) a solvent component that comprises water and one or more organic liquids, said solvent component exhibiting a δ p value of from 13.1 to 15.7 MPa ½ , and

b) a solute component that comprises

(1) a buffer provided by combining at least one carboxylic acid and conjugate base of at least one carboxylic acid,

(2) dissociation product of from 4 to 18 g/L of one or more electrolyte oxidizing agents, each of said electrolyte oxidizing agents being a compound that comprises an anion selected from the group consisting of manganate, permanganate, peroxochromate, chromate, dichromate, and peroxymonosulfate,

(3) from 0.05 to 1 g/L of a lysozyme,

(4) from 5 to 30 g/L of an anionic surfactant, and

(5) a nonionic surfactant,

said composition having a pH of from about 4.75 to about 6.5 and an effective solute concentration of at least 0.5 Osm/L.

13. The composition of claim 12 in which said effective solute concentration is at least 1.5 Osm/L.

14. The composition of claim 12 wherein said buffer comprises acetic acid and an alkali metal salt of acetic acid.

15. The composition of claim 12 wherein said buffer is provided by combining acetic acid and an alkali metal salt of acetic acid.

16. The composition of claim 12 wherein said solute component further comprises dissociation products of one or more non-oxidizing electrolytes.

17. The composition of claim 12 wherein said solute component comprises from 7 to 13 g/L of said one or more electrolyte oxidizing agents.

18. The composition of claim 12 wherein each of said electrolyte oxidizing agent compounds is inorganic.

19. The composition of claim 1 wherein each of said electrolyte oxidizing agent compounds is inorganic.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2025
From: NEXT SCIENCE IP HOLDINGS PTY LTD
To: OSARTIS GMBH
Reel/Frame 072590/0763 →
Continuity (3)
Provisional Application 62202644 · Aug 7, 2015
Provisional Application 62212552 · Aug 31, 2015
Related Publication 20180230408A1 · Aug 16, 2018
Cited By (1)
US 12,331,265